Tyrosine kinase inhibitors (TKIs) have sought great interest in recent years especially in the field of cancer research with promising results in clinical trials
IFNα2 was also the first IFN to be produced by the pharmaceutical industry for use as a drug
6 kDa Actual:120kDa Purity >95% by SDS-PAGE Endotoxin <1EU/mg Tag with C-10*His Physical Appearance Lyophilized Powder Storage Buffer Lyophilized from a 0
VPQKPKVSLNPPWNRIFKGENVTLTCNGNNFFEVSSTKWFHNGSLSEETNSSLNIVNAKFEDSGEYKCQHQQVNESEPVYLEVFSDWLLLQASAEVVMEGQPLFLRCHGWRNWDVYKVIYYKDGEALKYWYENHNISITNATVEDSGTYYCTGKVWQLDYESEPLNITVIKAPREKYWLGGGSGGGSPKSSDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK
The role of CD6 in autoimmune diseases may specifically reflect its interaction with CD318
Fas/TNFRSF6/CD95 Fc Chimera Protein, Rat Size:100μg Tyrosine kinase inhibitors (TKIs) haveProduct Specification Species Rat Synonyms FAS,ALPS1A,APO1,APT1,CD95,FAS1,FASTM,TNFRSF6,FasR Accession NP_631933. 2 Amino Acid Sequence Gln22 Lys170, with hIgG Fc Expression System HEK293 Molecular Weight 50 70kDa(R) Purity 95% by SDS PAGE & SEC HPLC Conjugation Unconjugated Tag Human Fc Tag Physical Appearance Lyophilized Powder Storage Buffer PBS, PH7. 4, 5% trehalose Reconstitution Reconstitute at 0. 1 1 mg ml according to the size in ultrapure